SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-23-058486
Filing Date
2023-12-20
Accepted
2023-12-19 19:38:51
Documents
1
Effectiveness Date
2023-12-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7835
  Complete submission text file 0001140361-23-058486.txt   9334
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-500205 | Film No.: 231499010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)